Elife Holdings Limited ( (HK:0223) ) has shared an announcement.
Elife Holdings Limited has announced updates regarding its ongoing forensic investigation and the appointment of an internal control consultant. The company is addressing issues related to unusual transactions by its subsidiaries during the 2024 Interim Period, which have delayed the publication of its interim results. The Independent Committee, after reviewing the McMillan Report, found it unsatisfactory due to its limited scope and lack of meaningful conclusions. Consequently, the committee has requested further work to meet the forensic investigation standards required by the Stock Exchange.
More about Elife Holdings Limited
Technical Sentiment Signal: Buy
Current Market Cap: €17.58M
See more insights into 0223 stock on TipRanks’ Stock Analysis page.